Horizon Kinetics Asset Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Horizon Kinetics Asset Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,726,520	Closed	-$2.24M	–	353
2022 Q3	$2.24M	Buy	1,726,520 +386,184	+29%	+$822K	0.05%	87
2022 Q2	$2M	Buy	1,340,336 +290,822	+28%	+$1.34M	0.04%	109
2022 Q1	$8.64M	Buy	+1,049,514	New	+$9.27M	0.17%	58

Other funds holding CORZ

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

STA

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Horizon Kinetics Asset Management's CORZ Position: Q4 2022 in Review

Horizon Kinetics Asset Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 1,726,520 shares — an estimated $2.24M sold.

Horizon Kinetics Asset Management first reported a position in CORZ in Q1 2022 and held it in 3 quarters. The position peaked at $8.64M in Q1 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

Horizon Kinetics Asset Management reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Horizon Kinetics Asset Management sold 1,726,520 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $2.24M.
Horizon Kinetics Asset Management first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Horizon Kinetics Asset Management's Core Scientific, Inc. Common Stock position peaked at $8.64M in Q1 2022.
89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.